Fortress Biotech, Inc. (FBIOP) News
Follow Fortress Biotech, Inc. (FBIOP) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Fortress Biotech to present at H.C. Wainwright conference
Fortress Biotech plans to present at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 08, 2026, 12:01 PM UTC
L
Fortress Biotech (FBIOP) reports Q2 2026 financial results
Fortress Biotech reports its second quarter 2026 financial results along with recent corporate highlights for FBIOP, according to TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 08:10 PM UTC
L
FBIO FBIOP - Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B FinancingProcee
FBIO FBIOP - Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B FinancingProceeds to support ongoing late-stage global clinical development and commercializati
EQUITY | Jul 27, 2026, 12:01 PM UTC